EMERGENT BIOSOLUTIONS INC. COMMON STOCK
7.3300
10-July-25 15:30:00
15 minutes delayed
Stocks
0.0000
0.00%
Today's range
7.2300 - 7.4150
ISIN
N/A
Source
NYSE
-
02 Jul 2025 15:05:19 By Nasdaq GlobeNewswire
-
23 Jun 2025 07:05:07 By Nasdaq GlobeNewswire
-
Emergent BioSolutions Announces Addition to Russell 3000® Index
20 Jun 2025 07:13:29 By Nasdaq GlobeNewswire
-
05 Jun 2025 06:00:21 By Nasdaq GlobeNewswire
-
Emergent BioSolutions to Participate in Upcoming Investor Conferences
14 May 2025 06:32:11 By Nasdaq GlobeNewswire
-
Emergent BioSolutions Reports First Quarter 2025 Financial Results
07 May 2025 15:05:02 By Nasdaq GlobeNewswire
-
01 May 2025 16:07:20 By Nasdaq GlobeNewswire
-
Emergent BioSolutions to Report First Quarter 2025 Financial Results on May 7, 2025
22 Apr 2025 06:59:59 By Nasdaq GlobeNewswire
-
Emergent BioSolutions Announces Stock Repurchase Program
31 Mar 2025 07:00:00 By Nasdaq GlobeNewswire
-
Emergent BioSolutions New Hire Equity Grant Under NYSE Rule 303A.08
20 Mar 2025 15:30:00 By Nasdaq GlobeNewswire
-
Hikma announces Health Canada approval of KLOXXADO® (naloxone HCl) Nasal Spray 8 mg
20 Mar 2025 07:06:17 By Nasdaq GlobeNewswire
-
19 Mar 2025 15:30:00 By Nasdaq GlobeNewswire
-
18 Mar 2025 07:00:00 By Nasdaq GlobeNewswire
-
13 Mar 2025 07:29:43 By Nasdaq GlobeNewswire
-
12 Mar 2025 07:00:26 By Nasdaq GlobeNewswire
-
10 Mar 2025 08:14:36 By Nasdaq GlobeNewswire
-
Emergent BioSolutions Reports Fourth Quarter and Full Year 2024 Financial Results
03 Mar 2025 15:23:25 By Nasdaq GlobeNewswire
-
Emergent BioSolutions to Report Fourth Quarter and Full Year 2024 Financial Results on March 3, 2025
18 Feb 2025 07:55:56 By Nasdaq GlobeNewswire
-
07 Feb 2025 07:06:54 By Nasdaq GlobeNewswire
- <<
- <
- 1
- >